Michael N. Hedrick

1.5k total citations
18 papers, 1.0k citations indexed

About

Michael N. Hedrick is a scholar working on Immunology, Parasitology and Molecular Biology. According to data from OpenAlex, Michael N. Hedrick has authored 18 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 5 papers in Parasitology and 4 papers in Molecular Biology. Recurrent topics in Michael N. Hedrick's work include Vector-borne infectious diseases (5 papers), Psoriasis: Treatment and Pathogenesis (5 papers) and T-cell and B-cell Immunology (5 papers). Michael N. Hedrick is often cited by papers focused on Vector-borne infectious diseases (5 papers), Psoriasis: Treatment and Pathogenesis (5 papers) and T-cell and B-cell Immunology (5 papers). Michael N. Hedrick collaborates with scholars based in United States, Germany and Japan. Michael N. Hedrick's co-authors include Joshua Μ. Farber, Hongwei H. Zhang, Satya P. Singh, John F. Foley, Juan Anguíta, Anke S. Lonsdorf, Tonya C. Bates, Chris M. Olson, Erol Fikrig and Elı́as R. Olivera and has published in prestigious journals such as Journal of Clinical Investigation, Nature Communications and The Journal of Immunology.

In The Last Decade

Michael N. Hedrick

18 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Michael N. Hedrick United States 13 691 192 183 177 122 18 1.0k
Joseph S. Murray United States 12 712 1.0× 110 0.6× 206 1.1× 71 0.4× 36 0.3× 22 1.2k
Katherine Bao United States 9 411 0.6× 115 0.6× 325 1.8× 61 0.3× 25 0.2× 13 921
Yusuke Tsujimura Japan 15 880 1.3× 158 0.8× 101 0.6× 91 0.5× 34 0.3× 27 1.3k
J F Gauchat France 11 871 1.3× 100 0.5× 261 1.4× 104 0.6× 33 0.3× 13 1.3k
Lionel Franz Poulin France 14 1.9k 2.7× 280 1.5× 471 2.6× 161 0.9× 29 0.2× 24 2.3k
Jonathan T. Sims United States 15 106 0.2× 133 0.7× 263 1.4× 106 0.6× 78 0.6× 29 741
E. Stüber Germany 7 1.2k 1.7× 221 1.2× 299 1.6× 42 0.2× 33 0.3× 19 1.9k
Jessica H. Spitzer United States 7 1.3k 1.9× 252 1.3× 249 1.4× 78 0.4× 21 0.2× 8 1.6k
Theresa Truitt United States 10 1.0k 1.5× 356 1.9× 255 1.4× 48 0.3× 18 0.1× 10 1.4k
Yasutaka Motomura Japan 20 1.3k 1.9× 146 0.8× 285 1.6× 68 0.4× 18 0.1× 30 1.7k

Countries citing papers authored by Michael N. Hedrick

Since Specialization
Citations

This map shows the geographic impact of Michael N. Hedrick's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael N. Hedrick with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael N. Hedrick more than expected).

Fields of papers citing papers by Michael N. Hedrick

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael N. Hedrick. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael N. Hedrick. The network helps show where Michael N. Hedrick may publish in the future.

Co-authorship network of co-authors of Michael N. Hedrick

This figure shows the co-authorship network connecting the top 25 collaborators of Michael N. Hedrick. A scholar is included among the top collaborators of Michael N. Hedrick based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael N. Hedrick. Michael N. Hedrick is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Wang, Zhaoqing, Charles Frost, Mario Callejo, et al.. (2022). New oral protease-activated receptor 4 antagonist BMS-986120: tolerability, pharmacokinetics, pharmacodynamics, and gene variant effects in humans. Platelets. 33(7). 969–978. 12 indexed citations
2.
Hedrick, Michael N., et al.. (2021). A flow cytometric assay for HLA‐DR expression on monocytes validated as a biomarker for enrollment in sepsis clinical trials. Cytometry Part B Clinical Cytometry. 100(1). 103–114. 24 indexed citations
3.
Sarikonda, Ghanashyam, Mélissa Mathieu, Anil Pahuja, et al.. (2020). Best practices for the development, analytical validation and clinical implementation of flow cytometric methods for chimeric antigen receptor T cell analyses. Cytometry Part B Clinical Cytometry. 100(1). 79–91. 25 indexed citations
4.
Sun, Yongliang, et al.. (2019). High-Throughput Analysis of Clinical Flow Cytometry Data by Automated Gating. Bioinformatics and Biology Insights. 13. 3079172483–3079172483. 15 indexed citations
5.
Singh, Tej Pratap, Izabela Borek, Peter Wolf, et al.. (2016). Monocyte-derived inflammatory Langerhans cells and dermal dendritic cells mediate psoriasis-like inflammation. Nature Communications. 7(1). 13581–13581. 124 indexed citations
6.
Hawley, Kelly L., Nicolás Navasa, Chris M. Olson, et al.. (2012). Macrophage p38 Mitogen-Activated Protein Kinase Activity Regulates Invariant Natural Killer T-Cell Responses During Borrelia burgdorferi Infection. The Journal of Infectious Diseases. 206(2). 283–291. 12 indexed citations
7.
Shirakawa, Aiko‐Konno, Fang Liao, Hongwei H. Zhang, et al.. (2010). Pathway-selective suppression of chemokine receptor signaling in B cells by LPS through downregulation of PLC-β2. Cellular and Molecular Immunology. 7(6). 428–439. 13 indexed citations
8.
Hedrick, Michael N., Anke S. Lonsdorf, Samuel Hwang, & Joshua Μ. Farber. (2010). CCR6 as a possible therapeutic target in psoriasis. Expert Opinion on Therapeutic Targets. 14(9). 911–922. 51 indexed citations
9.
Singh, Satya P., Maristela Martins De Camargo, Hongwei H. Zhang, et al.. (2010). Changes in histone acetylation and methylation that are important for persistent but not transient expression of CCR4 in human CD4+ T cells. European Journal of Immunology. 40(11). 3183–3197. 3 indexed citations
10.
Hedrick, Michael N., Anke S. Lonsdorf, Chyi‐Chia Richard Lee, et al.. (2009). CCR6 is required for IL-23–induced psoriasis-like inflammation in mice. Journal of Clinical Investigation. 119(8). 2317–2329. 188 indexed citations
11.
Singh, Satya P., Hongwei H. Zhang, John F. Foley, Michael N. Hedrick, & Joshua Μ. Farber. (2008). Human T Cells That Are Able to Produce IL-17 Express the Chemokine Receptor CCR6. The Journal of Immunology. 180(1). 214–221. 299 indexed citations
12.
Singh, Satya P., Hongwei Zhang, John F. Foley, Michael N. Hedrick, & Joshua Μ. Farber. (2008). Human T cells that are able to produce IL‐17 express the chemokine receptor CCR6. The FASEB Journal. 22(S1). 8 indexed citations
14.
Hedrick, Michael N., Chris M. Olson, Dietrich B. Conze, et al.. (2006). Control ofBorrelia burgdorferi-Specific CD4+-T-Cell Effector Function by Interleukin-12- and T-Cell Receptor-Induced p38 Mitogen-Activated Protein Kinase Activity. Infection and Immunity. 74(10). 5713–5717. 14 indexed citations
15.
Bates, Tonya C., et al.. (2005). Distinct bacterial dissemination and disease outcome in mice subcutaneously infected withBorrelia burgdorferiin the midline of the back and the footpad. FEMS Immunology & Medical Microbiology. 45(2). 279–284. 11 indexed citations
16.
Juncadella, Ignacio J., et al.. (2004). Delivery of the Immunosuppressive Antigen Salp15 to Antigen-Presenting Cells bySalmonella entericaSerovar TyphimuriumaroAMutants. Infection and Immunity. 72(6). 3638–3642. 3 indexed citations
17.
Anguíta, Juan, Michael N. Hedrick, & Erol Fikrig. (2003). Adaptation ofBorrelia burgdorferiin the tick and the mammalian host. FEMS Microbiology Reviews. 27(4). 493–504. 64 indexed citations
18.
Anguíta, Juan, Stephen W. Barthold, Michael N. Hedrick, et al.. (2002). Murine Lyme Arthritis Development Mediated by p38 Mitogen-Activated Protein Kinase Activity. The Journal of Immunology. 168(12). 6352–6357. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026